Journal Club The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes Prepared by:

Slides:



Advertisements
Similar presentations
What You Need to Know about Vitamin D Kelly Forrest, R.N.
Advertisements

Nutrients that prevent Cancer
What is vitamin D? Vitamin D is classified as a fat soluble vitamin
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.
Overcoming the challenge of blood pressure control in prediabetic and diabetic patients: PICASSO T2D Study Efficacy and tolerability of fixed dose combination.
CHROMIUM SUPPLEMENTATION DECREASES INSULIN RESISTANCE AND TRUNK FAT Ellie Aghdassi, Ph.D., Irving E Salit, MD., Saira Mohammed, MSc.,Bianca M Arendt, Ph.D.,
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
C ALCIUM AND V ITAMIN D Gila Greenbaum, Sodexo, Dietetic Intern 2014.
Amanda Sauer Dylan Spicer December 2010 Vitamin D Deficiency.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J CLIN ENDOCRINOL METAB, 97, , 2012.
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in T2DM Mellitus: a randomized, double-blind study. Dakhale GN,
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Vitamin D: From Sunshine to Supplements Family and Consumer Sciences Lesson.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
Chapter 10: Special Topics in Adults & Chronic Diseases: Nutrition and Public Health Judith Sharlin, PhD, RD.
1 The Study of Trandolapril- verapamil And insulin Resistance STAR determined whether glycaemic control was maintained to a greater degree by an RAS inhibitor/non-DHP.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
Assessment of Radial Pulse Wave Analysis, Insulin Resistance, and Glucose Homeostasis in African Americans at High Risk for Developing Type 2 Diabetes.
Blood pressure control in primary health care WORKSHOP
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Coagulation / Fibrinolytic Factors in PCOS. The Alternative Hypothesis : Conversely, PCOS women may be protected from later life onset of CHD by the altered.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Women’s Health 101. Objectives Leading causes of death in women How to prevent or manage leading health conditions Other health concerns for women Importance.
Salt, Heart Disease, and Stroke Norm Campbell. 1) The role of increased blood pressure as a determinant of adverse outcomes 2) The health risks of high.
And Its Effect on Health. What is vitamin D? Fat soluble vitamin Can be stored in the body via fat stores Stores can be used by the body in time of need.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
A Controlled Trial of Renal Denervation for Resistant Hypertension
Vitamin D andYOU. Vitamin D Toxicity It’s pretty hard to get too much vitamin D. Vitamin D is not nearly as toxic as overdoses of vitamin A and it is.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
By: Kristin Izzo Preceptors: Elizabeth Koustis, MS, RD Pamela Jessup, MS, RD WADE PARK NUTRITION CLINIC.
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease : The St Francis Heart Study Randomized Clinical Trial Temitope Foster,
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Angela Aziz Donnelly April 5, 2016
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
From ESH 2016 | POS 7D: Jan Rosa, MD
HOPE: Heart Outcomes Prevention Evaluation study
Vitamin D What is Vitamin D? The Sunshine Vitamin
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Dietary Consideration in Podiatric Practice
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
DiRECT (Diabetes Remission Clinical Trial)
What is Rippe Lifestyle institute?
Presentation transcript:

Journal Club The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes Prepared by: Amanda Bullock

Overview Vitamin D review Literature review Journal article ◦ Purpose ◦ Methods ◦ Results ◦ Conclusion Discussion

Vitamin D Health claims: ◦ Promotes healthy bones by assisting with calcium absorption ◦ Reduces risk of diabetes, heart disease, rheumatoid arthritis and multiple sclerosis ◦ Regulates immune system ◦ Prohibits cancer cell growth

Vitamin D Recommended blood level: 30-74ng/mL Food sources: ◦ Fatty fish: tuna, mackerel, salmon ◦ Cheese ◦ Egg yolks ◦ Fortified foods: milk, soy milk, orange juice

Vitamin D Best source: The SUN! ◦ Dubbed the “sunshine vitamin” ◦ Levels decrease during the winter months, especially if you are far from the equator

Literature Review Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. A randomized, controlled, double-blind study was performed on 100 non-diabetic insulin-resistant Asian females. Participants were given 4,000 IU of Vitamin D daily for 6 months.. (von Hurst, 2010)

Literature Review Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. When serum Vitamin D levels reached >32ng/mL, subjects showed significantly improved insulin resistance and sensitivity. (von Hurst, 2010)

Literature Review Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial A parallel-group, double-blind, placebo- controlled randomized trial was conducted with 159 subjects >70 years old who had low levels of Vitamin D and isolated systolic hypertension. 1,000 IU of Vitamin D or a placebo was administered each day. (Witham, 2013)

Literature Review Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial 12 months later when the study concluded, no improvement was seen in blood pressure or other markers of vascular health. (Witham, 2013)

Authors’ Review of Current Data “Vitamin D deficiency is more prevalent and severe in patients with type 2 diabetes compared with the normal population. Epidemiological studies revealed that vitamin D deficiency accompanied by type 2 diabetes is associated with an increased risk of all- cause and cardiovascular mortality.” (Ohk-Hyun, 2014)

Purpose Many claims have been made in support of Vitamin D supplementation, especially in regards to diabetes and heart disease This study aims to determine any impact on insulin resistance AND arterial stiffness secondary to Vitamin D supplementation in subjects with type 2 DM

Hypothesis Authors hypothesize that insulin resistance may link arterial stiffness and Vitamin D deficiency in type 2 DM… (Ohk-Hyun, 2014)

Subject Inclusion Criteria DM2 Vitamin D levels < 20ng/mL Ambulatory, aged years HbA1c levels % Unchanged medications 3 months prior to study Normal calcium levels BMI > 23 (Ohk-Hyun, 2014)

Subject Exclusion Criteria Use of osteoporosis-related medications within 3 months before study Use of insulin 1 month before study Systolic BP >160mmHg or diastolic BP >100mmHg Acute MI/stroke within 6 months Abnormal liver function test Alcoholism (Ohk-Hyun, 2014)

Methods: Design Prospective Randomized Double-blind Placebo-controlled (Ohk-Hyun, 2014)

Methods: Design For 24 weeks, participants received either: ◦ 1,000 IU Vitamin D with 100mg calcium twice daily (n = 40) --or-- ◦ Placebo containing 100mg of calcium twice daily (n = 41) (Ohk-Hyun, 2014)

Methods: Design Participants were evaluated at: ◦ Baseline ◦ 12 weeks +/- 2 weeks ◦ 24 weeks +/- 4 weeks (Ohk-Hyun, 2014)

Methods: Design All participants received education regarding Vitamin D rich foods Participants were instructed to maintain the same lifestyle as before the study (Ohk-Hyun, 2014)

Methods: Design Physicians not allowed to change antihypertensive, antiplatelet or antilipid drugs during the study. Only antidiabetic drugs allowed to be altered (Ohk-Hyun, 2014)

Methods: Outcome Measures Vitamin D levels Fasting glucose Lipid profiles HbA1c Insulin The homeostasis model of assessment-IR [HOMA-IR] High-sensitivity C- reactive protein (Ohk-Hyun, 2014)

Methods: Outcome Measures Brachial-ankle pulse wave velocity Radial augmentation index Central systolic blood pressure Safety of high-dose vitamin D supplementation ◦ Serum calcium ◦ Liver and kidney function (Ohk-Hyun, 2014)

Methods: Data Collection Blood pressure was tested after a 10- minute resting period Blood tests were drawn after an overnight fast from 7pm-9am Arterial stiffness was measured while the subject was in a supine position for 10 minutes (Ohk-Hyun, 2014)

Statistical Analysis At the conclusion of the study, subjects were evaluated if they: ◦ Took the supplements/placebo >80% of the time ◦ Didn’t change medications A value of p < 0.05 was considered to be significant Two-tailed t-tests were used to compare the Vitamin D and placebo group A chi-square test was also used for categorical variables (Ohk-Hyun, 2014)

Results Vitamin D levels (adequate = > 30 ng/mL): ◦ Placebo group: 10% (n = 3) ◦ Vitamin D group: 68.8% (n = 22) ◦ p < No significant change in arterial stiffness or insulin resistance between the two groups ◦ (No significant change in any outcome measure) (Ohk-Hyun, 2014)

Results Vitamin D supplementation at 2000 IU daily is safe in regards to liver/kidney function and serum calcium (Ohk-Hyun, 2014)

Conclusions No bias from the researchers was evident The conclusions are appropriate

EAL The evidence in this article receives an overall Fair (II) grade ElementsGrade QualityGood (I) ConsistencyFair (II) QuantityFair (II) Clinical ImpactLimited (III) GeneralizabilityFair (II)

Discussion Potential weaknesses of article: ◦ All subjects on different medications ◦ Low number or participants ◦ Not a high amount of Vitamin D tested

Discussion Discrepancies in conclusions of different articles ◦ More research needs to be done ◦ Consensus of a correlation between Vit D and metabolic syndrome

Discussion Questions If there is a link between Vitamin D deficiency and metabolic syndrome, should we fortify foods?

Discussion Questions Have any of you been asked about Vitamin D by patients? If so, what have they asked?

Discussion Questions If a link was proven between DM2 or cardiovascular disease and Vitamin D deficiency, do you think hospitals might incorporate supplements into clinical practice?

References 1. Ohk-Hyun R, Wankyo C, Sungwha L, Kyung-Soon H, Moon-Gi C, Hyung J Y. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med. 2014; 29(5): 620– von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient: a randomised, placebo- controlled trial. Br J Nutr. 2010; 103: 549– Witham MD, Price RJ, Struthers AD, et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med. 2013; 173: 1672–1679.